Corvus Pharmaceuticals Inc. (CRVS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Corvus Pharmaceuticals In...

    NASDAQ: CRVS · Real-Time Price · USD
    5.74
    0.33 (6.10%)
    At close: Aug 29, 2025, 3:59 PM
    5.71
    -0.55%
    After-hours: Aug 29, 2025, 07:44 PM EDT

    Corvus Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -5.24 -3.13 -0.96 -2.33
    PEG Ratio
    		 -0.06 0.08 0.07 -0.01
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 10.02 2.18 0.71 1.04
    P/FCF Ratio
    		 -12.83 -3.53 -1.45 -2.75
    P/OCF Ratio
    		 -12.83 -3.53 -1.46 -2.75
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.03 0.04 0.05 0.04
    Quick Ratio
    		 1.54 4.07 4.13 7.43
    Current Ratio
    		 1.54 4.07 4.06 7.36
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -15.1 -14.78 -49.79 -2.58K
    Return on Equity
    		 -1.91 -0.7 -0.74 -0.45
    Return on Assets
    		 -0.9 -0.59 -0.61 -0.4
    Return on Invested Capital
    		 -0.81 -0.56 -0.53 -0.37
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist